Publications by authors named "RJ Bruni"

Claim this Profile
M
Measurement of p.
KA Brown, RJ Bruni, PR Cameron, DG Crabb, RL Cummings

Phys Rev D Part Fields· June 1985

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of diaminouracil metabolites of caffeine in human urine.
A R Branfman, M F McComish, R J Bruni, M M Callahan, R Robertson

Drug Metab Dispos· September 1983

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of combination therapy with continuous-infusion PALA and continuous-infusion 5-FU.
G R Weiss, T J Ervin, M W Meshad, D Schade, A R Branfman, R J Bruni

Cancer Chemother Pharmacol· December 1982

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitation of the antitumor agent N-(phosphonacetyl)-L-aspartic acid in human plasma and urine by gas chromatography-mass spectrometry-selected ion monitoring.
A R Branfman, R J Bruni, Y N Merrill, M Chadwick, J M Strong

J Chromatogr· May 1980

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the metabolites of ellipticine in rat bile.
A R Branfman, R J Bruni, V N Reinhold, D M Silveira, M Chadwick

Drug Metab Dispos· January 1979

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new class of antimalarial drugs: derivatives of benzothiopyrans.
R K Razdan, R J Bruni, A C Mehta, K K Weinhardt, Z B Papanastassiou

J Med Chem· July 1978

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gas chromatography and mass spectrometry of N-(phosphonacetyl)-L-aspartic acid.
A R Branfman, K H Valia, R J Bruni

J Chromatogr· April 1978

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aromatic hydroxylation of ellipticine in rats: lack of an NIH shift.
V N Reinhold, R J Bruni

Biomed Mass Spectrom· December 1976

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of new metabolites of daunomycin and adriamycin.
F J Bullock, R J Bruni, M A Asbell

J Pharmacol Exp Ther· July 1972

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential carcinolytic agents. VII. Substituted bis(2-methanesulfonoxyethyl)anilines.
Z B Papanastassiou, R J Bruni, P B Estes, I Wodinsky

J Med Chem· September 1969

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential carcinolytic agents. VI. New deactivated biological alkylating agents.
Z B Papanastassiou, R J Bruni, E White

Experientia· April 1968

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential carcinolytic agents. V. Enamine mustards.
Z B Papanastassiou, R J Bruni, E White

J Med Chem· July 1967

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential carcinolytic agents. IV. Diazoamino mustards.
Z B Papanastassiou, R J Bruni, E White, V Levins, P L Levins

J Med Chem· September 1966

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential carcinolytic agents. 3. Fluoronitrogen mustard analogs of cyclophosphamide.
Z B Papanastassiou, R J Bruni, F P Fernandes, P L Levins

J Med Chem· May 1966

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential antiradiation drugs. II. 2-Amino-1-alkanethiols, 1-amino-2-alkanethiols, 2-thiazolines, and 2-thiazoline-2-thiols.
G R Handrick, E R Atkinson, F E Granchelli, R J Bruni

J Med Chem· November 1965

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis